@Article{,
AUTHOR = {Ashley B. King, David E. Rapp},
TITLE = {Prolonged urinary retention after intravesical botulinum injection for treatment of  idiopathic detrusor overactivity},
JOURNAL = {Canadian Journal of Urology},
VOLUME = {18},
YEAR = {2011},
NUMBER = {2},
PAGES = {5657--5659},
URL = {http://www.techscience.com/CJU/v18n2/61953},
ISSN = {1488-5581},
ABSTRACT = {<b>Introduction:</b> Botulinum toxin (BTX) has emerged as a treatment of refractory overactive bladder (OAB) and, while well tolerated, there exists concern regarding postoperative urinary retention.<br/>

<b>Case:</b> A 75-year-old female underwent intravesical BTX-A injection, which was followed by a prolonged episode of urinary retention, highlighting an unusual duration and degree of UR associated with BTX-A injection in the treatment of idiopathic detrusor overactivity (IDO). This case illustrates clinically significant urinary retention with bladder diaries demonstrating persistent postvoid residual (PVR) measurements exceeding voided volume until 9 month follow up.<br/>

<b>Conclusions:</b> Notably, this duration and severity of urinary retention remains rare. However, this case underscores the need to appropriately counsel patients regarding the risks associated with intravesical injection of BTX-A.},
DOI = {}
}